Neuroscience
Neuromuscular Disorder
100%
Personality Disorder
66%
Anxiety Disorder
66%
Sleep Disorder
66%
Parkinson's Disease
66%
Mood Disorder
66%
Psychosis
66%
Neurotrauma
66%
Traumatic Brain Injury
66%
Eating Disorder
66%
Multiple Sclerosis
66%
Headache
66%
Somatoform Disorder
66%
Cerebrovascular Accident
66%
Intracranial Tumor
66%
Addiction
33%
Migraine
33%
Mental Disorder
33%
Psychological Treatment
33%
Neurological Disorder
33%
Head
33%
Brain Disease
33%
Keyphrases
Europe
100%
Brain Disorders
100%
Neuromuscular Disease
21%
Intellectual Disability
14%
Headache
14%
Cost Estimation
14%
Parkinson's Disease
14%
Anxiety Disorders
14%
Epilepsy
14%
Health Economics
14%
Personality Disorders
14%
Dementia
14%
Sleep Disorders
14%
Eating Disorders
14%
Multiple Sclerosis
14%
Age Groups
14%
Psychotic Disorders
14%
Economic Data
14%
Traumatic Brain Injury
14%
Indirect Costs
14%
Somatoform Disorders
14%
Direct Costs
14%
Brain Tumor
14%
Direct Medical Costs
14%
Long-term Disability
14%
Cost Model
14%
Cost Items
14%
Uncertainty Sources
7%
High Cost
7%
European Countries
7%
Politicians
7%
National Government
7%
Epidemiological Data
7%
Inflation
7%
Administrative Data
7%
Medical School
7%
Euro
7%
Public Health
7%
Social Networks
7%
High Prevalence
7%
Psychological Treatment
7%
Mental Disorders
7%
Mood Disorders
7%
Emotional Burden
7%
Addiction
7%
Epidemiologic
7%
Health-related
7%
Switzerland
7%
Financial Burden
7%
Migraine
7%
Purchasing Power Parity
7%
Neurological Disorders
7%
Economic Burden
7%
Norway
7%
Economic Challenges
7%
Healthcare Expenditure
7%
Age of Diagnosis
7%
Total Annual Cost
7%
Developmental Disorders
7%
Economical Evaluation
7%
European Healthcare
7%
Improved Cost
7%
Social Burden
7%
Iceland
7%
Pharmaceutical Industry
7%
Stakeholder Groups
7%
Neurologic
7%
Diagnosis-related Groups
7%
Affective Disorders
7%
EU-27
7%
Population Increase
7%
12-month Prevalence
7%
Estimated Cost
7%
Brain Research
7%
Current Science
7%
National Statistics
7%
New EU Member States
7%
Patient Advocacy Groups
7%
Eurostat
7%
Local Currency
7%
Production Loss
7%
Addictive Disorders
7%
Political Action
7%
Diagnostic Classification Models
7%
Preadolescent children
7%
Disorders Diagnosis
7%
Cost of Goods
7%
INIS
cost
100%
brain
100%
europe
100%
silicon carbides
86%
data
31%
nervous system diseases
20%
economics
17%
patients
13%
reviews
10%
tumors
6%
epilepsy
6%
populations
6%
range
6%
panels
6%
injuries
6%
adolescents
6%
industry
6%
coverings
6%
sleep
6%
age groups
6%
diseases
3%
levels
3%
values
3%
power
3%
member states
3%
education
3%
policy
3%
schools
3%
children
3%
recommendations
3%
spectra
3%
losses
3%
production
3%
classification
3%
people
3%
pharmaceuticals
3%
statistics
3%
expenditures
3%
national government
3%
public health
3%
teaching
3%
inflation
3%
parity
3%
switzerland
3%
norway
3%
extrapolation
3%
iceland
3%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Prevalence
9%
Neuromuscular Disease
9%
Anxiety Disorder
6%
Sleep Disorder
6%
Parkinson's Disease
6%
Mood Disorder
6%
Multiple Sclerosis
6%
Traumatic Brain Injury
6%
Eating Disorder
6%
Psychosis
6%
Headache
6%
Cerebrovascular Accident
6%
Somatoform Disorder
6%
Intracranial Tumor
6%
Personality Disorder
6%
Brain Disease
3%
Neurologic Disease
3%
Addiction
3%
Migraine
3%
Developmental Disorder
3%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Adolescence
66%
Social Network
33%